EICHORPublic-registry site landscape for NCT04969510, “A Clinical Trial of Adjunctive and Monotherapy PRAX-114 in Participants With Major Depressive Disorder”, a Major Depressive Disorder study sponsored by Praxis Precision Medicines. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04969510 (registry record) |
| Study title | A Clinical Trial of Adjunctive and Monotherapy PRAX-114 in Participants With Major Depressive Disorder |
| Official title | A Phase 2 Double-blind, Placebo-Controlled, Dose-Ranging Clinical Trial to Evaluate the Efficacy and Safety of PRAX-114 in Adjunctive and Monotherapy Treatment of Participants With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment |
| Sponsor | Praxis Precision Medicines |
| Condition(s) | Major Depressive Disorder |
| Phase | PHASE2 |
| Listed sites | 24 |
| Site countries | United States, Australia |
Patient-friendly overview of this study: eichor.com/study/NCT04969510.
Eichor generates a preliminary site-risk snapshot for NCT04969510 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
Other Major Depressive Disorder trials
More from Praxis Precision Medicines
← Eichor home · All tracked trials · Major Depressive Disorder studies · Weekly briefs
